TMEM185B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.096200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.308800E-01
Normal-vs-Stage2
5.246400E-01
Normal-vs-Stage3
7.907200E-01
Normal-vs-Stage4
3.718400E-01
Stage1-vs-Stage2
8.532200E-01
Stage1-vs-Stage3
4.394200E-01
Stage1-vs-Stage4
4.176400E-01
Stage2-vs-Stage3
2.755800E-01
Stage2-vs-Stage4
4.293000E-01
Stage3-vs-Stage4
2.598200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.135400E-01
Normal-vs-AfricanAmerican
2.249800E-01
Normal-vs-Asian
9.891400E-01
Caucasian-vs-AfricanAmerican
1.344390E-01
Caucasian-vs-Asian
3.374200E-01
AfricanAmerican-vs-Asian
1.344360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.282200E-01
Normal-vs-Female
5.844000E-01
Male-vs-Female
8.003200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.608800E-01
Normal-vs-Age(41-60Yrs)
3.988800E-01
Normal-vs-Age(61-80Yrs)
7.612800E-01
Normal-vs-Age(81-100Yrs)
5.482000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.123000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.419000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.340200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.583850E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.598600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.002800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.698800E-01
Normal-vs-Daily Drinker
9.647200E-01
Normal-vs-Weekly Drinker
3.786600E-01
Normal-vs-Occasional Drinker
3.776400E-01
Normal-vs-Social Drinker
4.016400E-01
Non Drinker-vs-Daily Drinker
6.665600E-01
Non Drinker-vs-Weekly Drinker
1.094790E-01
Non Drinker-vs-Occasional Drinker
8.814100E-02
Non Drinker-vs-Social Drinker
1.877240E-01
Daily Drinker-vs-Weekly Drinker
8.352500E-02
Daily Drinker-vs-Occasional Drinker
6.588200E-02
Daily Drinker-vs-Social Drinker
1.283180E-01
Weekly Drinker-vs-Occasional Drinker
9.970800E-01
Weekly Drinker-vs-Social Drinker
7.234600E-01
Occasional Drinker-vs-Social Drinker
7.103200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.117800E-01
Normal-vs-Grade 2
7.923600E-02
Normal-vs-Grade 3
6.801800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.580800E-03
Grade 1-vs-Grade 3
9.026600E-04
Grade 1-vs-Grade 4
4.117800E-01
Grade 2-vs-Grade 3
1.016980E-01
Grade 2-vs-Grade 4
7.923600E-02
Grade 3-vs-Grade 4
6.801800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.563000E-01
Normal-vs-NonDiabetic
5.956400E-01
Diabetic-vs-NonDiabetic
2.729400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.499400E-01
Normal-vs-NoPancreatitis
6.536600E-01
Pancreatitis-vs-NoPancreatitis
8.581600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.908200E-01
Normal-vs-N1
5.006200E-01
N0-vs-N1
3.571400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.731600E-01
Normal-vs-TP53-NonMutant
9.462400E-01
TP53-Mutant-vs-TP53-NonMutant
4.04370000000043E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
